Clinical Trial Update: The Effects of Atorvastatin on the Nitric Oxide-system in Patients With Non-diabetic Nephropathy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the effects of atorvastatin on the nitric oxide system in patients with non-diabetic nephropathy; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Non-diabetic Nephropathy

Drugs mentioned

• Lipitor (atorvastatin)

Snippet

Sponsor: Erling Bjerregaard Pedersen | Conditions: Nephropathy, Cardiovascular Diseases | Phase 2 | Status: COMPLETED